维昇药业-B（股票代码：02561）于2026年7月6日披露截至2026年6月30日的股份变动月报。公告显示，公司法定股本为500,000,000股普通股，面值为每股0.0001美元，合计50,000美元，与上月一致。
本月末已发行股份（不含库存股份）共计113,753,364股，较上月减少123,800股；库存股份数由49,700股增至173,500股，总股本维持在113,926,864股不变。报告期内未有新增发售或注销情况，相关股份变动主要由于公司在6月回购合计123,800股并将其持作库存股份。
公司同时披露，月内无期权授予或行使，也未见其他股权激励计划下的股份发行活动。根据公告，截至月末公司仍符合最低公众持股量要求。
公司声称已遵守香港联交所《上市规则》及相关法律法规，并确认上述回购及股份变动均获董事会正式授权和批准。公告由执行董事卢安邦签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.